References
- Sharifi, N. & Steinman, R.A. Targeted chemotherapy: chronic myelogenous leukemia as a model. J. Mol. Med. 80, 219-232 (2002) https://doi.org/10.1007/s00109-001-0305-3
- Goldman, J.M. & Melo, J.V. Chronic myeloid leukemia advances in biology and new approach to treatment. New Engl. J. Med. 349, 1451-1464 (2003) https://doi.org/10.1056/NEJMra020777
- Savage, D.G. & Antman, K.H. Imatinib mesylate?a new oral targeted therapy. N. Engl. J. Med. 346, 683- 693 (2002) https://doi.org/10.1056/NEJMra013339
- Koo, J.Y. et al. Quantitative determination of amygdalin epimers from armeniacae semen by liquid chromatography. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 814, 69-73 (2005) https://doi.org/10.1016/j.jchromb.2004.10.019
- Cho, C.J. et al. Hyundae-Saengyak-Hak. 8th ed. Hak- Chang Press, Seoul, pp. 470-472 (1998)
- Newmark, J. et al. Amygdalin (Laetrile) and prunasin beta-glucosidases: distribution in germ-free rat and in human tumor tissue. Proc. Natl. Acad. Sci. USA. 78, 6513-6516 (1981)
- Flora, K.P., Cradock, J.C. & Ames, M.M. A simple method for the estimation of amygdalin in the urine. Res. Commun. Chem. Pathol. Pharmacol. 20, 367- 378 (1978)
- Khandekar, J.D. & Edelman, H. Studies of amygdalin (laetrile) toxicity in rodents. JAMA 242, 169-171 (1979) https://doi.org/10.1001/jama.242.2.169
- Moertel, C.G. et al. A pharmacologic and toxicological study of amygdalin. JAMA 245, 591-594 (1998) https://doi.org/10.1001/jama.245.6.591
- Kwon, H.Y., Hong, S.P., Hahn, D.H. & Kim, J.H. Apoptosis induction of Persicae Semen extract in human promyelocytic leukemia (HL-60) cells. Arch. Pharm. Res. 26, 157-161 (2003) https://doi.org/10.1007/BF02976663
- Kawabe, T. G2 checkpoint abrogators as anticancer drugs. Mol. Cancer Ther. 3, 513-519 (2004)
- Wang, Z. DNA damage-induced mutagenesis: a novel target for cancer prevention. Mol. Interv. 1, 269-281 (2001)
- Mainprize, T.G., Taylor, M.D., Rutka, J.T. & Dirks, P.B. Cip/Kip cell-cycle inhibitors: A neuro-oncological perspective. J. Neurooncol. 51, 205-218 (2001) https://doi.org/10.1023/A:1010671908204
- Schwartz, G.K. & Shah, M.A. Targeting the cell cycle: a new approach to cancer therapy. J. Clin. Oncol. 23, 9408-9421 (2005) https://doi.org/10.1200/JCO.2005.01.5594
- Mailand, N. et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425-1429 (2000) https://doi.org/10.1126/science.288.5470.1425
- Mailand, N. et al. Regulation of G (2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO 21, 5911-5920 (2002) https://doi.org/10.1093/emboj/cdf567
- Eastman, A. Cell cycle checkpoints and their impact on anticancer therapeutic strategies. J. Cell Biochem. 91, 223-231 (2004) https://doi.org/10.1002/jcb.10699
- Falck, J. et al. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410, 842-847 (2001) https://doi.org/10.1038/35071124
- Hirama, T. & Koeffler, H.P. Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86, 841-854 (1995)
- Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3, 231-234 (1997) https://doi.org/10.1038/nm0297-231
- Matsuoka, S. et al. p57Kip2, a structurally distinct member of the p21cip1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650- 662 (1995) https://doi.org/10.1101/gad.9.6.650
- Sherr, C.J. & Roberts, J.M. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999) https://doi.org/10.1101/gad.13.12.1501
- Sheaff, R.J. et al. Cyclin E-CDK2 is a regulator of p27 (Kip1). Genes Dev. 11, 1464-1478 (1997) https://doi.org/10.1101/gad.11.11.1464
- Lee, M.H., Reynisdottir, I. & Massague, J. Cloning of p57 (KIP2), a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649 (1995) https://doi.org/10.1101/gad.9.6.639
- Yang, Y.H. et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002) https://doi.org/10.1093/nar/30.4.e15